F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2016
NCT02837939
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica | F.D.Roosevelt Teaching Hospital with policlinic, Banska Bystrica, Slovakia, 97517 | Head Dept Internal Medicine F.D.Roosevelt Teaching Hospital Banska Bystrica Slovakia | Study Principal Investigator F.D.Roosevelt Teaching Hospital, Banska Bystrica, Slovakia

Active Ingredients

Drugs in Phase 4 Trials (1)

silymarin (1 trial)

Drugs in Phase 3 Trials (2)

human fecal microbiota (Reybota) (1 trial)

human transfer factor (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fibrosis (Phase 3)

Hepatic Insufficiency (Phase 3)

Liver Cirrhosis (Phase 3)

Liver Failure (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3